← Back

Wire · opportunities

Senseonics, Beta Bionics integrate diabetes technology

Published

18 November 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at medtechdive.com →

◆ Verified

Fusion42 · 18 November 2026 · Fusion42 review

Senseonics and Beta Bionics have integrated their diabetes management technologies, combining an implantable glucose monitor Eversense 365 with the iLet Bionic Pancreas insulin pump to simplify automated insulin delivery and reduce user burden.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You can now offer a smoother diabetes management experience by combining implantable glucose sensing with automated insulin delivery. This integration opens a path to reduce daily diabetes care tasks and makes your product more attractive to users seeking convenience.

◆ Coverage

1 source · 18 Nov 2026

◆ Related on Wire

◆ Topics

Medtechdiabetes-techimplantable-cgminsulin-pumpautomationmedtech